普萊得(301353.SZ):目前暫時還沒有進入機器人領域的戰略佈局規劃
格隆匯7月11日丨有投資者向普萊得(301353.SZ)提問,“貴司生產的減速器主要是什麼類型的,能否應用於工業機器人和人形機器人?隨着國家出台了人形機器人的發展政策,貴司是否有考慮加入這片藍海市場?”
普萊得回覆稱,公司的主要產品為電動工具,減速器為電動工具的零部件,系公司自主研發和生產;公司將繼續深耕電動工具領域,並根據所處市場環境、經營情況、產業政策等因素變化制定公司發展戰略,目前暫時還沒有進入機器人領域的戰略佈局規劃。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.